Home Med-Fine Family: Ansong Tech Closes ~CNY 150M C3 Round; Lingke Pharma's NDA for Zeprucitinib Accepted by NMPA

Med-Fine Family: Ansong Tech Closes ~CNY 150M C3 Round; Lingke Pharma's NDA for Zeprucitinib Accepted by NMPA

May 29, 2026 09:00 CST Updated 12:01
Allink Biotherapeutics

Innovative Drug Developer

Lynk Pharmaceuticals

FIC/BIC Small Molecule Drug Developer